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Background: Severe neurological signs that develop during acute infection by virulent strains of Babesia bovis are
associated with sequestration of infected erythrocytes in cerebral capillaries. Serial passage of virulent strains in
cattle results in attenuated derivatives that do not cause neurologic disease. We evaluated whether serial passage
also results in a loss of cerebral capillary sequestration by examining brain biopsies during acute disease and at
necropsy.
Findings: Cerebral biopsies of spleen intact calves inoculated intravenously with a virulent or attenuated strain pair of B.
bovis were evaluated for capillary sequestration at the onset of babesiosis and during severe disease. In calves infected
with the virulent strain, there was a significant increase in sequestration between the first and second biopsy timepoint.
The attenuated strain was still capable of sequestration, but at a reduced level, and did not change significantly between
the first and second biopsy. Necropsy examination confirmed the second biopsy results and demonstrated that
sequestration identified at necropsy reflects pathologic changes occurring in live animals.
Conclusions: Loss of neurovirulence after serial in vivo passage of the highly virulent T2Bo strain of B. bovis in
splenectomized animals is associated with a significant reduction of cerebral capillary sequestration. Previous genomic
analysis of this and two other strain pairs suggests that this observation could be related to genomic complexity,
particularly of the ves gene family, rather than consistent gene specific differences. Additional experiments will examine
whether differential gene expression of ves genes is also associated with reduced cerebral sequestration and
neurovirulence in attenuated strains.
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Background
Babesia bovis is a tick-borne apicomplexan parasite that
infects cattle in tropical and sub-tropical regions world-
wide. Neurological signs may accompany fever and
anemia during acute infection by many virulent strains
[1]. Neurovirulence is associated with infected erythro-
cytes cytoadhering to endothelial cells, which subse-
quently leads to sequestration within cerebral capillaries
[2-4]. Attenuated strains of B. bovis incapable of indu-
cing neurovirulence are derived in vivo through rapid* Correspondence: kss@vetmed.wsu.edu
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distribution, and reproduction in any mediumserial passage of parental virulent strains, and are cur-
rently used as live vaccines in endemic regions [5]. Loss
of neurovirulence associated-attenuation is hypothesized
to be due to loss of endothelial cell cytoadherence and
sequestration. However, the absence of sequestration has
not been proven experimentally, particularly in live
animals during acute infection. The mechanism of
cytoadherence is postulated to involve endothelial cell
binding of infected erythrocytes through interaction
of the large protein gene family, Variant Erythrocyte
Surface Antigen (VESA)-1, with the endothelial cell sur-
face, similar to the mechanism of sequestration and
neurovirulence in falciparum malaria involving the
PfEMP1 protein family [6,7].
In this study, we tested whether the loss of neuro-
virulence in animals infected with the attenuated strainntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Temporal evaluation of capillary sequestration was per-
formed in vivo by cerebral biopsies during acute infec-
tion, and in tissues taken at necropsy.
Methods
Strains
The T2Bo virulent strain of B. bovis and an attenuated de-
rivative strain obtained after 29 passages in splenectomized
calves was utilized. The virulent parental (T2Bo_vir) and at-
tenuated derivative strains (T2Bo_att) have been previously
validated to reflect their designated phenotypes of neuro-
virulence and non-neurovirulence, respectively [8].
Animals
The study utilized spleen intact Holstein cattle >12months
of age. Calves were initially obtained at 3–6 months of
age from a Washington State dairy, quarantined at the
Washington State University Animal Resource Unit, and
given health checks at the Veterinary Teaching Hospital
(College of Veterinary Medicine, Washington State
University). All cattle were free of previous B. bovis
infection as determined by sourcing from the United
States (which is declared free of bovine babesiosis by the
World Organization for Animal Health) and by confirm-
ation through the absence of serum antibody and parasites
by cELISA (VMRD, Pullman, WA) and qPCR, respect-
ively, as previously described [9]. All animal procedures
were approved by the Animal Care and Use Committee,
#ASAF 03322–002.
Brain biopsy
Two groups of spleen intact cattle (n = 2 for each group)
were intravenously inoculated with blood stabilates
containing 2 × 107 infected erythrocytes (iRBC) of
T2Bo_vir or T2Bo_att strain. Rectal temperature,
hematocrit, and parasitemia were monitored daily. One
day after the onset of fever (>103°F), animals were anes-
thetized, placed in sternal recumbency, and a brain bi-
opsy performed at the Veterinary Teaching Hospital
(Washington State University, Pullman WA). Cerebral
cortical tissue was obtained using a 14 gauge side-
cutting disposable brain biopsy needle (Ad-Tech, Racine
WI). Multiple 2 mm × 1 cm pieces of biopsy tissue
were fixed in 10% buffered neutral formalin for sub-
sequent microscopic evaluation. Following the first
biopsy, each animal was recovered from anesthesia
and clinical signs monitored. The biopsy process was
repeated within 2–3 days when clinical parameters
indicated severe clinical disease. All animals were
euthanized after the second biopsy while under
anesthesia to evaluate capillary sequestration levels
after the cessation of blood flow.Post-mortem brain and tissue samples were collected
in duplicate. One sample was placed in 10% buffered
neutral formalin for fixation, and the second sample was
frozen in liquid nitrogen for DNA extraction and qPCR
analysis.
Microscopic evaluation
Formalin fixed tissues were paraffin embedded, cut into
5 micron sections, placed on glass slides and stained
with Giemsa (Washington Animal Disease Diagnostic
Laboratory). Sequestration of B. bovis iRBC in tissue ca-
pillaries was evaluated histologically by counting a mini-
mum of 100 erythrocytes (RBC) in longitudinal sections
of capillaries. Manual counts were performed in dupli-
cate at 63X magnification, and the average percentage of
infected erythrocytes (iRBC) in capillaries was deter-
mined for each tissue using the formula: (iRBC/total
RBC) × 100. All tissue sections were examined by the
same individual without knowledge of which strain the
animal was inoculated with.
Quantitative PCR on collected tissues
Genomic DNA was extracted from frozen tissues (brain,
lung, heart, kidney, liver, spleen, and skin) stored at −80°C.
Tissues were thawed, homogenized and lysed using MP
Biomedicals lysing matrix A as per manufacturer’s rec-
ommendation (MP Biomedicals, Solon OH). Following
the first centrifugation step, the supernatant was incu-
bated at 56°C with proteinase K from the Qiagen Blood
and Tissue DNA Extraction Kit (Qiagen, Valencia, CA),
and extracted following the manufacturer’s recommenda-
tion (Qiagen, Valencia, CA). Equivalent starting amounts
of tissues (0.1 g) were processed in triplicate for each
animal from each group. Quantitative PCR (qPCR)
was performed using a previously published protocol
targeting the merozoite surface antigen-1 gene (msa-1),
with the exception of the 5′ primer (5′-GAT GCG TTT
GCA CAT GCT AAG-3′). A positive control containing
10 ng of T2Bo gDNA, and negative control of naïve cow
gDNA were included [9,10].
Statistical analysis
Comparative analysis of sequestration at different biopsy
time points, and tissue parasitemia, were analyzed using a
2-way ANOVA with repeated measures or 2-way
ANOVA, respectively, with each followed by Bonferroni’s
multiple comparison tests. A one-tailed student’s t-test
was used for parasitemia comparison in blood (Graphpad
Prism v. 5.0a).
Results
A cerebral cortical biopsy was obtained from all infected
animals at the onset of clinical signs as determined by
the first day of fever (103°F) (Figure 1A). All biopsied
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(1.1 mg/kg) to control localized inflammation and pain,
which resulted in a slight decrease in body temperature
in three of four animals. To avoid any confounding ef-
fect from this treatment, the second biopsies were
obtained in both groups when severe clinical disease
with fever was present (Figure 1A).
Cerebral sequestration of iRBC was observed in both
T2Bo_vir and T2Bo_att infected animals throughout the
experiment (Figure 1B). There was no significant differenceFigure 1 Sequential evaluation of cerebral capillary sequestration dur
changes in rectal temperature during infection. Animals infected with T2Bo
arrows at days 6 and 8 indicate the first and second biopsy for T2Bo_vir in
and second biopsy, respectively, for T2Bo_att infected animals. (B) Represe
T2Bo_att infected group. First biopsy (panels 1 and 4) was taken one day f
2–3 days following the first biopsy. Panels 3 and 6 represent samples taken
brain biopsies. There is a significant difference in sequestration between fir
necropsy (p < 0.0001) for the T2Bo_vir group. A significant difference betwe
(p < 0.05) was also observed.in sequestration levels between T2Bo_vir and T2Bo_att
infected animals at the onset of clinical signs (biopsy 1).
However, the sequestration level in the T2Bo_vir infected
animals increased significantly between the first and sec-
ond biopsy (mean of 10.1% and 75.6% iRBC, respect-
ively; p < 0.0001), as well as between the first biopsy and
necropsy (mean of 10.1% and 82.8% iRBC, respectively;
p < 0.0001) (Figure 1C). In contrast, there was no signifi-
cant elevation in sequestration level in T2Bo_att infected
animals between the first and second biopsy or first biopsying acute babesiosis. (A) The timing of biopsy correlated with
_vir are in red, and animals infected with T2Bo_att are in blue. The red
fected animals. The blue arrows at days 7 and 9–10 indicate the first
ntative photomicrographs of brain biopsies of either the T2Bo_vir or
ollowing the onset of fever. Second biopsy (panels 2 and 5) was taken
within one hour of death. (C) Levels of sequestration observed in
st and second biopsies (p < 0.0001), as well as first biopsy and
en the T2Bo_vir and T2Bo_att groups for second biopsy and necropsy
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ively). The capillary sequestration level between T2Bo_vir
and T2Bo_att infected animals at the time of the second
biopsy and necropsy were also significantly different
(Figure 1C, mean of 75.6% vs 23.6% (second biopsy),
and 82.8% vs 29.0% (necropsy), respectively; p < 0.05).
The only statistically significant differences in the level
of parasite numbers between the T2Bo_vir and T2Bo_att
groups were in the cerebrum and kidney, with signifi-
cantly higher number of parasites found in the T2Bo_vir
group (Table 1). This observation could be due to the
tissue-tropism of the virulent strain and corroborates
previous reports of sequestration of virulent strains of B.
bovis in brain and renal capillaries [2].
While in vivo brain biopsies provide a unique analysis
during acute disease, the challenges of performing these
biopsies in large animals limits the total number of ani-
mals that can be examined in a study. Nonetheless, even
with a small group size, our findings that the overall se-
questration was lower in T2Bo_att infected animals than
those infected with the parental virulent strain are statis-
tically significant. Factors that may impact these results
include variation in the initial or circulating parasite
load, and differences in innate or adaptive immune re-
sponse to parental and attenuated strains. Since the
number of infected erythrocytes used in the inoculum
for both groups was the same, the experiment was ter-
minated prior to development of a protective immune re-
sponse, and the time course of the experiment varied by
only two days, the differential tissue sequestration levels
observed are likely due to the nature of the inocula.
The presence of sustained sequestration with no signs of
neurovirulence leads us to conclude that cytoadherence
and sequestration, while associated with neurovirulence,
may not be solely responsible. One explanation of the
findings is that the attenuated strain may have reverted to
neurovirulence once introduced back into a spleen-intact
animal, a phenomenon reported experimentally in B. bovis
[5,11] and in Plasmodium spp. [12-14]. However, in the
field this is uncommon as attenuated strains of B. bovisTable 1 Parasite numbers in tissue (copies/g) of T2Bo_vir
and T2Bo_att infected animals
Tissue T2Bo_vir [SEM] T2Bo_att [SEM]
Cerebrum 8.92E + 05a [3.14E + 05] 2.06E + 05 [6.80E + 04]
Lung 6.91E + 04 [6.10E + 03] 2.07E + 04 [6.27E + 03]
Heart 2.70E + 05 [6.49E + 04] 5.21E + 04 [1.44E + 04]
Liver 4.41E + 04 [1.23E + 04] 1.30E + 04 [1.47E + 03]
Kidney 1.26E + 06a [3.31E + 05] 1.09E + 05 [1.98E + 04]
Spleen 6.44E + 05 [3.16E + 05] 9.15E + 04 [4.11E + 04]
Skin 0.00E + 00 [0.00E + 00] 0.00E + 00 [0.00E + 00]
aSignificant difference between the two groups in the cerebrum (p < .05) and
kidney (p < .0001).have been used for extended periods as field vaccines
without reversion to virulence [1]. The lack of neuro-
virulence in animals infected with T2Bo_att could be due
to repertoire differences of parasite-derived proteins in-
volved with cytoadhesion, such as the VESA1, which may
then affect the binding of iRBC with endothelial cell re-
ceptors [15,16]. Comparative genome analysis of T2Bo_vir
and T2Bo_att strains reveals genomic diversity reduction,
including changes in the ves gene repertoire [8]. This find-
ing supports the suggestion that genomic differences may
contribute to phenotypic variability. Alternatively, a thresh-
old level of iRBC cytoadherence within cerebral capillaries
may be necessary for clinically expressed neurovirulence.Conclusion
We hypothesized that the lack of neurovirulence in
T2Bo_att infected animals is associated with an absence
of cytoadherence and sequestration in cerebral capillar-
ies. Our results demonstrate that attenuation with loss
of neurovirulence does result in a significant reduction,
but not total elimination of sequestration. Ongoing ex-
periments will analyze transcriptomic expression profiles
between the two members of this strain pair, and evalu-
ate additional strain pairs in order to better understand
the mechanisms of attenuation.Competing interests
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